Trastuzumab, Pertuzumab, and Docetaxel as the First Line for HER-2-Positive Metastatic Breast Cancer among Arabs.
Suleman K, Mushtaq AH, Haque E, Badran AA, Ajarim D, Elashwah AM, Gad AM, Abdelsamad AS, Omar A, Khan KA, Al-Tweigeri T, Elshentenawy A, Alsayed A.
Suleman K, et al. Among authors: badran aa.
Breast Care (Basel). 2021 Feb;16(1):59-65. doi: 10.1159/000506824. Epub 2020 Apr 6.
Breast Care (Basel). 2021.
PMID: 33716633
Free PMC article.